Evaluation of outcomes in patients (pts) with stage 4 non-small cell lung cancer (NSCLC 4) harboring actionable oncogenic drivers (AOD) when treated prior to report of mutation without tyrosine kinase inhibitors (TKI): An Integra Connect Database (ICD) retrospective observational study. Article (Faculty180)

cited authors

  • Smith, Robert E.; Johnson, Melissa Lynne; Gordan, Lucio N.; Xue, Mei; Varughese, Prateesh; Dorrow, Natalie A.; Wang, Brandon; Vaidya, Varun; Gart, Mike; Gierman, Hinco J.; Scott, Jeffrey A.


publication date

  • 2022

published in

start page

  • 1530

end page

  • 1530


  • 40